Rep. Hank Johnson discussed the impact of Georgia’s biosciences sector, and CPAC supports FTC action against PBMs. We have details, plus more news on bird flu, USDA biofuel grants, and more. Don’t ...
Eric Marandett, co-chair of Choate’s Intellectual Property Litigation Practice Group, represents biotech, pharmaceutical, and technology companies in high stakes patent litigation and other ...
October is the scariest time of year. Young goblins walk the streets demanding treats, local haunted houses are packed full of fright-chasing teens, and the airwaves are filled with gore-splattered ...
We’ve got lots to cover this week—including what to expect on Mexico’s corn ban, what Sen. Bill Cassidy MD said about FDA’s Orange Book, and more news on price controls and bird flu. (871 words, 4 ...
Building on the success of the campaign to date, BIO is announcing a new series produced for us by BBC StoryWorks and launching in 2025. In this new iteration, the series will build on the ...
BIO represents more than 1,000 biotechnology companies, academic institutions, state biotechnology centers and related organizations in all 50 U.S. states and 33 other nations. BIO members are ...
"BIO is a crucial trade group representing all biotech and biopharma companies with influence on policies affecting our business and patients with rare diseases in the U.S. Through our participation ...
To be eligible for membership in BIO, a firm or organization must fit into one of the membership categories outlined in BIO’s bylaws (i.e., Core, Associate, Affiliate, and Center members). Further, ...
BIO is committed to supporting biobased breakthroughs at all stages of development and technology developers of all types and sizes. From public education campaigns to pushing for regulations that ...
Explore how we drive biotechnology innovation. Advancing newer and better medicines, therapeutics, and vaccines is a collective effort that involves an entire ecosystem, not just one person or company ...
Trust is fundamental to the adoption of new technologies. Showcasing the science, efficacy, and need for transformational technologies will help to build trust among diverse stakeholder groups—whether ...